Inicio › Enfermedad de obstrucción pulmonar crónica › Texas › Dallas
Ensayos clínicos de Enfermedad de obstrucción pulmonar crónica en Dallas, TX
13 estudios para Enfermedad de obstrucción pulmonar crónica buscan participantes en centros de Dallas y alrededores (a unos 30 millas). Abra un estudio para ver quién puede participar y cómo contactar con el equipo.
Texto oficial del estudio (inglés)
A Non-inferiority Pharmacokinetic and Safety/Tolerability Study of Two Different Doses of Weekly SC Alpha1-PI 15% Compared With Corresponding Standard IV Alpha1-PI in Participants With Alpha1-Antitrypsin Deficiency (AATD)
ReclutandoFase 3
- GC2501 Study Site 109, Dallas
A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2
- Research Site, Dallas
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- IntraCare- Site Number : 8400034, Dallas
A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
ReclutandoFase 2/3
- Alina Clinical Trials, LLC., Dallas
- Baylor Scott & White Advanced Lung Disease Specialists, Dallas
- Baylor University Medical Center (Research Office), Dallas
- y 1 más
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
ReclutandoFase 3
- Texas Health Presbyterian Hospital Dallas- Site Number : 8400032, Dallas
STRIVE Post-Market Registry Study
ReclutandoEstudio observacional
- Baylor Scott & White Research Institute, Dallas
- University of Texas Southwestern, Dallas
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
ReclutandoFase 3
- GSK Investigational Site, Dallas
Depemokimab as an Extended Treatment Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Dallas
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
ReclutandoFase 3
- Research Site, Dallas
An Evaluation of the AeriSeal System for CONVERTing Collateral Ventilation Status in Patients With Severe Emphysema
Reclutando
- University of Texas Southwestern, Dallas
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
ReclutandoFase 3
- Research Site, Dallas
eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
ReclutandoFase 3
- GSK Investigational Site, Dallas
Collection of Blood From Healthy Patients, Patients With Benign Disease and Patients With Cancer
ReclutandoEstudio observacional
- Liver Center of Texas, Dallas
Más información sobre Enfermedad de obstrucción pulmonar crónica en MedlinePlus
Ensayos de Enfermedad de obstrucción pulmonar crónica en otras ciudades
- Philadelphia, PA26 estudios
- Miami, FL20 estudios
- Houston, TX18 estudios
- Birmingham, AL17 estudios
- Baltimore, MD16 estudios
- Boston, MA15 estudios
- Orlando, FL15 estudios
- Chicago, IL15 estudios
- New York City, NY12 estudios
- Pittsburgh, PA11 estudios
- Winston-Salem, NC11 estudios
- Hialeah, FL10 estudios
Otros estudios en Dallas
- Cáncer de seno54 estudios
- Cáncer de pulmón de células no pequeñas53 estudios
- Cáncer metastásico44 estudios
- Fallo cardíaco42 estudios
- Cáncer (todos los tipos)40 estudios
- Cáncer de próstata39 estudios
- Cáncer del colon y del recto34 estudios
- Obesidad33 estudios
- Cáncer de ovario31 estudios
- Cáncer de vejiga27 estudios
- Cáncer de pulmón26 estudios
- Cáncer de endometrio25 estudios
De ClinicalTrials.gov, datos obtenidos el 15 nov 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.